The study will assess PNM-CAP's ability to prevent neuroma, chronic pain, and opioid use PITTSBURGH, Dec. 3, 2025 /PRNewswire/ -- Renerva, Inc., a medical device company developing solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results